Literature DB >> 25496311

A phospholipid complex to improve the oral bioavailability of flavonoids.

Huizhen Wang1,2, Yuqing Cui1, Qingxue Fu3, Bing Deng1, Guowen Li4, Jun Yang2, Tao Wu3, Yan Xie1.   

Abstract

AIM: A phospholipid complex (TFH-PC) was prepared to increase the oral bioavailability of isorhamnetin, kaempferol, and quercetin from TFH (total flavones of Hippophae rhamnoides L.).
METHODS: Solvent evaporation was used to prepare TFH-PC. Relevant parameters were investigated based on the complexation rate of isorhamnetin, kaempferol, and quercetin. Fourier transform infrared spectroscopy (FT-IR), differential scanning calorimetry (DSC), X-ray power diffraction (X-RPD), and scanning electron microscopy (SEM) were used for characterization. Solubility, octanol-water partition coefficient (log P), dissolution rate, and in vivo pharmacokinetics were also investigated.
RESULTS: TFH-PC was successfully prepared in tetrahydrofuran with a drug to phospholipid ratio of 1:1, reaction temperature of 20 °C, and a reaction time of 1 h. The complexation rates of isorhamnetin, kaempferol, and quercetin were 97.7%, 95.97%, and 92.23%, respectively. FT-IR, DSC, X-RPD, and SEM confirmed the formation of TFH-PC. The aqueous solubilities of the three flavonoids in TFH-PC increased 22.0-26.8-fold compared with TFH. The dissolution of isorhamnetin, kaempferol, and quercetin in TFH-PC was 84.32%, 90.77%, and 100% within 10 min, respectively, greatly improved over TFH. After oral administration of TFH-PC in rats, the bioavailability of isorhamnetin, kaempferol, and quercetin in TFH-PC relative to TFH was 223%, 172%, and 242%, respectively.
CONCLUSION: The oral absorption of isorhamnetin, kaempferol, and quercetin was significantly improved in TFH-PC, mainly due to increased solubility and dissolution rate. This phospholipid complex shows potential for oral delivery of the flavonoids in TFH.

Entities:  

Keywords:  Dissolution rate; flavonoids; oral absorption; phospholipid complex; solubility

Mesh:

Substances:

Year:  2014        PMID: 25496311     DOI: 10.3109/03639045.2014.991402

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  5 in total

Review 1.  Discovery and Current Status of Evaluation System of Bioavailability and Related Pharmaceutical Technologies for Traditional Chinese Medicines--Flos Lonicerae Japonicae--Fructus Forsythiae Herb Couples as an Example.

Authors:  Wei Zhou; Baochang Cai; Jinjun Shan; Shouchuan Wang; Liuqing Di
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

2.  Transdermal delivery of triptolide-phospholipid complex to treat rheumatoid arthritis.

Authors:  Xin-Yi Liu; Wen-Jun Pei; Ye-Zhen Wu; Fang-Li Ren; Si-Yu Yang; Xiu Wang
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

3.  Novel self-nanomicellizing solid dispersion based on rebaudioside A: a potential nanoplatform for oral delivery of curcumin.

Authors:  Yuzhen Hou; Hui Wang; Fan Zhang; Fengyuan Sun; Meng Xin; Mengshuang Li; Jun Li; Xianggen Wu
Journal:  Int J Nanomedicine       Date:  2019-01-11

4.  A Solid Dispersion of Quercetin Shows Enhanced Nrf2 Activation and Protective Effects against Oxidative Injury in a Mouse Model of Dry Age-Related Macular Degeneration.

Authors:  Yan Shao; Haitao Yu; Yan Yang; Min Li; Li Hang; Xinrong Xu
Journal:  Oxid Med Cell Longev       Date:  2019-11-07       Impact factor: 6.543

Review 5.  Natural compounds as inhibitors of SARS-CoV-2 endocytosis: A promising approach against COVID-19.

Authors:  Aysha Karim Kiani; Kristjana Dhuli; Kyrylo Anpilogov; Simone Bressan; Astrit Dautaj; Munis Dundar; Tommaso Beccari; Mahmut C Ergoren; Matteo Bertelli
Journal:  Acta Biomed       Date:  2020-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.